OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) Director Richard C. Pfenniger, Jr. bought 25,000 shares of the stock in a transaction on Friday, January 5th. The stock was purchased at an average price of $0.94 per share, with a total value of $23,500.00. Following the completion of the purchase, the director now owns 325,000 […]
OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) was the target of unusually large options trading on Thursday. Traders acquired 3,010 call options on the company. This is an increase of 497% compared to the average volume of 504 call options. Insider Buying and Selling In other news, Director Richard C. Pfenniger, Jr. acquired 25,000 […]
Altium Capital Management LP acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,588,000 shares of the company’s stock, valued at approximately $1,675,000. Altium Capital Management LP owned 18.97% of GeneDx at the […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) Director Richard C. Pfenniger, Jr. purchased 5,000 shares of the business’s stock in a transaction dated Thursday, August 17th. The stock was bought at an average cost of $5.10 per share, for a total transaction of $25,500.00. Following the purchase, the director now owns 10,918 shares in […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) Director Richard C. Pfenniger, Jr. bought 5,000 shares of GeneDx stock in a transaction dated Thursday, August 17th. The shares were acquired at an average cost of $5.10 per share, for a total transaction of $25,500.00. Following the completion of the purchase, the director now directly owns […]